Mendel Money Management Pfizer Inc Transaction History

Mendel Money Management

$215 Million
Q3 2025

A detailed history of Mendel Money Management transactions in Pfizer Inc stock. As of the latest transaction made, Mendel Money Management holds 16,260 shares of PFE stock, worth $407,800. This represents 0.19% of its overall portfolio holdings.

Number of Shares

16,260

Previous 18,257 10.94%

Holding current value

$407,800

Previous $442,000 6.33%

% of portfolio

0.19%

Previous 0.22%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$23.29 - $25.88 $46,510 - $51,682	-1,997 Reduced 10.94%	16,260 $414,000
Q2 2025 Aug 01, 2025	SELL	$21.59 - $24.84 $8,636 - $9,936	-400 Reduced 2.14%	18,257 $442,000
Q4 2024 Feb 11, 2025	BUY	$24.8 - $30.19 $4,216 - $5,132	170 Added 0.92%	18,657 $494,000
Q3 2024 Nov 07, 2024	BUY	$27.7 - $31.39 $17,174 - $19,461	620 Added 3.47%	18,487 $535,000
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $14,271 - $16,724	-565 Reduced 3.07%	17,867 $499,000

Q1 2024 May 01, 2024	BUY	$25.89 - $29.73 $149,644 - $171,839	5,780 Added 45.68%	18,432 $511,000
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $330,596 - $429,408	12,652 New	12,652 $364,000
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $15,563 - $18,192	-485 Reduced 3.24%	14,472 $480,000
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $15,242 - $17,635	-422 Reduced 2.74%	14,957 $548,000
Q1 2023 May 10, 2023	SELL	$39.39 - $51.28 $34,190 - $44,511	-868 Reduced 5.34%	15,379 $627,000
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $16,491 - $21,527	-395 Reduced 2.37%	16,247 $832,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $81,874 - $99,948	1,871 Added 12.67%	16,642 $728,000
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $83,195 - $98,643	-1,788 Reduced 10.8%	14,771 $774,000
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $408,730 - $506,468	8,934 Added 117.17%	16,559 $857,000
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $57,021 - $84,525	-1,380 Reduced 15.32%	7,625 $450,000
Q3 2021 Nov 09, 2021	BUY	$39.25 - $50.42 $3,728 - $4,789	95 Added 1.07%	9,005 $387,000
Q2 2021 Aug 11, 2021	SELL	$35.91 - $40.68 $2,513 - $2,847	-70 Reduced 0.78%	8,910 $349,000
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $24,782 - $27,949	-740 Reduced 7.61%	8,980 $325,000
Q4 2020 Feb 09, 2021	BUY	$33.47 - $42.56 $23,429 - $29,792	700 Added 7.76%	9,720 $358,000
Q3 2020 Nov 10, 2020	SELL	$31.75 - $37.25 $4,762 - $5,587	-150 Reduced 1.64%	9,020 $331,000
Q2 2020 Jul 29, 2020	BUY	$30.12 - $36.54 $12,048 - $14,616	400 Added 4.56%	9,170 $300,000
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $4,938 - $5,604	150 Added 1.74%	8,770 $344,000
Q3 2019 Nov 08, 2019	SELL	$32.49 - $42.13 $272,591 - $353,470	-8,390 Reduced 49.32%	8,620 $310,000
Q2 2019 Aug 08, 2019	BUY	$36.98 - $41.52 $78,027 - $87,607	2,110 Added 14.16%	17,010 $737,000
Q3 2018 Oct 29, 2018	SELL	$34.47 - $41.81 $249,183 - $302,244	-7,229 Reduced 32.67%	14,900 $657,000
Q4 2017 Feb 06, 2018	BUY	$33.26 - $35.29 $736,010 - $780,932	22,129	22,129 $802,000

Others Institutions Holding PFE

# of Institutions

3,368

Shares Held

3.57B

Call Options Held

86.1M

Put Options Held

105M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mendel Money Management, based on Form 13F filings with the SEC.

News

Stay updated on Mendel Money Management with notifications on news.

Account

Mendel Money Management Pfizer Inc Transaction History